Strategies to Preserve Beta-Cell Function in Newly Diagnosed Type 1-Diabetes
Received Date: Sep 02, 2024 / Published Date: Sep 30, 2024
Abstract
Type 1 diabetes (T1D) is an autoimmune disorder characterized by the destruction of insulin-producing beta cells in the pancreas. This leads to absolute insulin deficiency, necessitating lifelong insulin therapy. Recent research emphasizes the importance of preserving residual beta-cell function in newly diagnosed T1D patients, as it can improve glycemic control and reduce complications. This article explores various strategies to preserve beta-cell function, including immunotherapy, lifestyle modifications, and novel pharmacological interventions.
Keywords: Type 1 diabetes; Beta-cell function; immunotherapy; GLP-1 agonists; SGLT-2 inhibitors; Lifestyle modifications; Continuous glucose monitoring; Diabetes management
Citation: Thompson L (2024) Strategies to Preserve Beta-Cell Function in Newly Diagnosed Type 1-Diabetes. J Diabetes Clin Prac 7: 267 Doi: 10.4172/jdce.1000267
Copyright: © 2024 Thompson L. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
